莫凤珍

莫凤珍，药学副教授，硕士研究生导师，医学博士学位，药剂学教研室教师， 从事《药剂学》、《药事管理学》等课程的教学与科研，主持校级教改课题2项，校级教学成果奖三等奖1项。研究领域：肿瘤免疫治疗、递药系统的构建与评价。发表科研论文10余篇，作为主要参与人获广西科学技术自然科学奖二等奖 1项。

代表性论文（第一作者/通讯作者）：

1.Fengzhen Mo; Siliang Duan; Xiaobing Jiang; Xiaomei Yang; Xiaoqiong Hou; Wei Shi; Cueva Jumbo Juan Carlos; Aiqun Liu; Shihua Yin; Wu Wang; Hua Yao; Zihang Yu; Zhuoran Tang; Shenxia Xie; Ziqiang Ding; Xinyue Zhao; Bruce D. Hammock; XiaoLing Lu ; Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy, Signal Transduction and Targeted Therapy, 2021, 6(1): 80-91.

2.Fengzhen Mo; Dabing Xue; Siliang Duan; Aiqun Liu; Xiaomei Yang; Xiaoqiong Hou; Xiaoling Lu ; Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitopeand dendritic cells effectively target cancer, Vaccine, 2019, 37(7): 926-936.